CHAPTER
49

 
 

USAMRIID

 

Platt took over the small conference room next door to his office. He made a pot of coffee and ate an apple he found in his desk drawer. He started retrieving, sorting and compiling information. In no time he had the contents of file folders spilled across the tabletop. On his laptop computer he accessed documents, browsed and read and printed out pages that went into a separate stack. And on a legal pad he scrawled a series of lists and notes.

On one page he jotted bits and pieces about Ebola Zaire.

The symptoms:

 

First stage (within 1–2 days of infection) :
fever, severe headache, sore throat, muscle aches, weakness, nosebleed.

 

Next stage (within a week, as little as 3 days) :
vomiting, abdominal pain, jaundice, diarrhea, conjunctivitis (red eyes).

 

Final stage (7–21 days) :
tissue destruction, organ failure, massive hemorrhaging, shock, respiratory arrest, death.

 

On a separate pile was everything he could find about the vaccine, including a copy of the original report that first appeared in the Journal Public Library of Science Pathogens, January 2007. The research team that developed the vaccine had been from Canada’s National Microbiology Laboratory in Winnipeg and USAMRIID, right here at Fort Detrick.

On another page he scribbled pieces about the vaccine:

Most effective when giving injections in a series (comparable to rabies shots)

Administered after infection within 30 minutes—90% survival rate.

24 hours after infection—50% survival rate.

 

Administered before infection—potential for the vaccine to protect but unproven to date.

 

Tests to date all performed on macaque monkeys. Human trials limited. Not enough data to establish survival rates.

 

Not approved by the FDA.

 

Would require an emergency “compassionate use” permit.

 

Platt underlined “compassionate use.” He wouldn’t have time to make an argument to the FDA, but as part of a military research facility he would try to find an exception. He’d do whatever it took. Janklow had said that there were sacrifices that often had to be made in war zones and in hot zones. The same was true about exceptions.

He remembered Afghanistan and a makeshift medical facility in the back of a truck. Every time they came under fire the protocol was to move, get the hell out, but in the middle of an amputation no way could you rumble to safety. So you sat in the line of fire, trying to keep the soldier on the gurney from bleeding to death and hoping all of you didn’t get blown apart.

No one ever questioned breaking protocol. You did what you had to do under special circumstances. Protect and serve. You certainly didn’t leave a soldier behind to bleed to death and you didn’t stand back and watch while four people under your care crashed.

In a short time, Platt was finished. He packed up what he needed, left the mess in the conference room to clean up later, locking the door behind him. Then he headed back up to the labs, the confidence back in his stride. As the head of the facility he required no other signature but his own. He didn’t need Janklow. He didn’t needed McCathy. All he needed now was the vaccine.

Maggie O'Dell #06 - Exposed
titlepage.xhtml
Exposed_split_000.html
Exposed_split_001.html
Exposed_split_002.html
Exposed_split_003.html
Exposed_split_004.html
Exposed_split_005.html
Exposed_split_006.html
Exposed_split_007.html
Exposed_split_008.html
Exposed_split_009.html
Exposed_split_010.html
Exposed_split_011.html
Exposed_split_012.html
Exposed_split_013.html
Exposed_split_014.html
Exposed_split_015.html
Exposed_split_016.html
Exposed_split_017.html
Exposed_split_018.html
Exposed_split_019.html
Exposed_split_020.html
Exposed_split_021.html
Exposed_split_022.html
Exposed_split_023.html
Exposed_split_024.html
Exposed_split_025.html
Exposed_split_026.html
Exposed_split_027.html
Exposed_split_028.html
Exposed_split_029.html
Exposed_split_030.html
Exposed_split_031.html
Exposed_split_032.html
Exposed_split_033.html
Exposed_split_034.html
Exposed_split_035.html
Exposed_split_036.html
Exposed_split_037.html
Exposed_split_038.html
Exposed_split_039.html
Exposed_split_040.html
Exposed_split_041.html
Exposed_split_042.html
Exposed_split_043.html
Exposed_split_044.html
Exposed_split_045.html
Exposed_split_046.html
Exposed_split_047.html
Exposed_split_048.html
Exposed_split_049.html
Exposed_split_050.html
Exposed_split_051.html
Exposed_split_052.html
Exposed_split_053.html
Exposed_split_054.html
Exposed_split_055.html
Exposed_split_056.html
Exposed_split_057.html
Exposed_split_058.html
Exposed_split_059.html
Exposed_split_060.html
Exposed_split_061.html
Exposed_split_062.html
Exposed_split_063.html
Exposed_split_064.html
Exposed_split_065.html
Exposed_split_066.html
Exposed_split_067.html
Exposed_split_068.html
Exposed_split_069.html
Exposed_split_070.html
Exposed_split_071.html
Exposed_split_072.html
Exposed_split_073.html
Exposed_split_074.html
Exposed_split_075.html
Exposed_split_076.html
Exposed_split_077.html
Exposed_split_078.html
Exposed_split_079.html
Exposed_split_080.html
Exposed_split_081.html
Exposed_split_082.html
Exposed_split_083.html
Exposed_split_084.html
Exposed_split_085.html
Exposed_split_086.html
Exposed_split_087.html
Exposed_split_088.html
Exposed_split_089.html
Exposed_split_090.html
Exposed_split_091.html
Exposed_split_092.html
Exposed_split_093.html
Exposed_split_094.html